# FDA Inspection 869722 - Biomat USA Inc - March 04, 2014

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/935b1afe-4aae-4d3e-b1c6-03a23ff0d4ea
Source feed: FDA_Inspections

> FDA Inspection 869722 for Biomat USA Inc on March 04, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 869722
- Company Name: Biomat USA Inc
- Inspection Date: 2014-03-04
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1112924 - 2019-11-07](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/eb0a66bb-bd78-443c-af14-f2cb5213e1e9)
- [FDA Inspection 1029273 - 2017-09-06](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/ad8d5c69-60eb-4af3-9864-a35cba5f2598)
- [FDA Inspection 816888 - 2013-02-04](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/352f4bf1-292f-46ea-a1c9-d63af57d9c9b)
- [FDA Inspection 708048 - 2011-01-28](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/102f2d98-8795-424b-a73a-d81d2fafc79c)

Company: https://www.keypedia.com/companies/biomat-usa-inc/81a864d8-045f-4585-8784-7b0b66373c49

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d